---
figid: PMC7564201__cancers-12-02623-g005
figtitle: Cross-talk of PPARG with other receptors in breast cancer cells
organisms:
- Mus musculus
- Rattus norvegicus
- Trifolium pratense
- Euonymus alatus
- Homo sapiens
- Mouse mammary tumor virus
- Thunnus alalunga
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC7564201
filename: cancers-12-02623-g005.jpg
figlink: pmc/articles/PMC7564201/figure/cancers-12-02623-f005/
number: F5
caption: Cross-talk of PPARγ with other receptors in breast cancer cells. PPARγ ligands
  inhibit the leptin transcription and leptin-induced activation of JAK-STAT (Janus
  kinase/signal transducers and activators of transcription) and MAPK (mitogen-activated
  protein kinase) signaling. Moreover, ligand-activated PPARγ interferes with the
  human epidermal growth factor receptor 2/3 (HER2/HER3) pathway, decreases aromatase
  expression, trans represses the estrogen receptor α (ERα) target genes, and interacts
  with ERα antagonizing the activation of survival phosphatidylinositol 3-kinase (PI3K)/AKT
  (protein kinase B) signaling cascade, thus regulating breast cancer proliferation.
papertitle: 'The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical
  Studies.'
reftext: Giuseppina Augimeri, et al. Cancers (Basel). 2020 Sep;12(9):2623.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9602609
figid_alias: PMC7564201__F5
figtype: Figure
redirect_from: /figures/PMC7564201__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7564201__cancers-12-02623-g005.html
  '@type': Dataset
  description: Cross-talk of PPARγ with other receptors in breast cancer cells. PPARγ
    ligands inhibit the leptin transcription and leptin-induced activation of JAK-STAT
    (Janus kinase/signal transducers and activators of transcription) and MAPK (mitogen-activated
    protein kinase) signaling. Moreover, ligand-activated PPARγ interferes with the
    human epidermal growth factor receptor 2/3 (HER2/HER3) pathway, decreases aromatase
    expression, trans represses the estrogen receptor α (ERα) target genes, and interacts
    with ERα antagonizing the activation of survival phosphatidylinositol 3-kinase
    (PI3K)/AKT (protein kinase B) signaling cascade, thus regulating breast cancer
    proliferation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - ERBB3
  - LEPR
  - ESR1
  - ERAL1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - PGR
  - PPARA
  - PPARD
  - PPARG
  - PARPBP
  - Erbb2
  - Erbb3
  - Lepr
  - Esr1
  - Eral1
  - Akt1
  - Pgr
  - Ppara
  - era
  - MKP-4
  - p38b
  - rl
  - Akt
  - gr
  - pgc
  - gre
  - Rosiglitazone
---
